Patterns and functional roles of LINE-1 and Alu methylation in the keratinocyte from patients with psoriasis vulgaris

Journal of Human Genetics

Volumn 60, Issue 7, 2015, Pages 349-355

  Yooyongsatit, Surasak ^a   Ruchusatsawat, Kriangsak ^b   Noppakun, Nopadon ^a   Hirankarn, Nattiya ^a   Mutirangura, Apiwat ^a   Wongpiyabovorn, Jongkonnee ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALU GENE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; DNA MODIFICATION; DOWN REGULATION; EPIGENETICS; EVALUATION STUDY; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; HUMAN; KERATINOCYTE; LINE 1 GENE; MALE; PSORIASIS VULGARIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; AGED; ALU SEQUENCE; CASE CONTROL STUDY; CELL CULTURE; GENETIC EPIGENESIS; GENETICS; LONG INTERSPERSED REPEAT; METABOLISM; MIDDLE AGED; PATHOLOGY; PSORIASIS; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; ALU ELEMENTS; CASE-CONTROL STUDIES; CELLS, CULTURED; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION; HUMANS; KERATINOCYTES; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX;

EID: 84938080262     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2015.33     Document Type: Article

References (36)

1. Cordaux, R. & Batzer, M. A. The impact of retrotransposons on human genome evolution. Nat. Rev. Genet. 10, 691-703 (2009
2. Kazazian, H. H. Jr & Moran, J. V. The impact of L1 retrotransposons on the human genome. Nat. Genet. 19, 19-24 (1998
3. Aporntewan, C., Phokaew, C., Piriyapongsa, J., Ngamphiw, C., Ittiwut, C. & Tongsima, S. et al. Hypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2. PLoS One 6, e17934 (2011
4. Han, J. S., Szak, S. T. & Boeke, J. D. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 429, 268-274 (2004
5. Chisholm, K. M., Aubert, S. D., Freese, K. P., Zakian, V. A., King, M. C. & Welcsh, P. L. A genomewide screen for suppressors of Alu-mediated rearrangements reveals a role for PIF1. PLoS One 7, e30748 (2012
6. Kitkumthorn, N. & Mutirangura, A. Long interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications. Clin. Epigenetics 2, 315-330 (2011
7. Speek, M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol. Cell Biol. 21, 1973-1985 (2001
8. Phokaew, C., Kowudtitham, S., Subbalekha, K., Shuangshoti, S. & Mutirangura, A. LINE-1 methylation patterns of different loci in normal and cancerous cells. Nucleic Acids Res. 36, 5704-5712 (2008
9. Chalitchagorn, K., Shuangshoti, S., Hourpai, N., Kongruttanachok, N., Tangkijvanich, P. & Thong-ngam, D. et al. Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis. Oncogene 23, 8841-8846 (2004
10. Estecio, M. R., Gharibyan, V., Shen, L., Ibrahim, A. E., Doshi, K. & He, R. et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2, e399 (2007
11. Perrin, D., Ballestar, E., Fraga, M. F., Frappart, L., Esteller, M. & Guerin, J. F. et al. Specific hypermethylation of LINE-1 elements during abnormal overgrowth and differentiation of human placenta. Oncogene 26, 2518-2524 (2007
12. Shuangshoti, S., Hourpai, N., Pumsuk, U. & Mutirangura, A. Line-1 hypomethylation in multistage carcinogenesis of the uterine cervix. Asian Pac. J. Cancer Prev. 8, 307-309 (2007
13. Pattamadilok, J., Huapai, N., Rattanatanyong, P., Vasurattana, A., Triratanachat, S. & Tresukosol, D. et al. LINE-1 hypomethylation level as a potential prognostic factor for epithelial ovarian cancer. Int. J. Gynecol. Cancer 18, 711-717 (2008
14. Moore, L. E., Pfeiffer, R. M., Poscablo, C., Real, F. X., Kogevinas, M. & Silverman, D. et al. Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol. 9, 359-366 (2008
15. Karouzakis, E., Gay, R. E., Michel, B. A., Gay, S. & Neidhart, M. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 60, 3613-3622 (2009
16. Nakkuntod, J., Avihingsanon, Y., Mutirangura, A. & Hirankarn, N. Hypomethylation of LINE-1 but not Alu in lymphocyte subsets of systemic lupus erythematosus patients. Clin. Chim. Acta. 412, 1457-1461 (2011
17. Lee, H. S., Kim, B. H., Cho, N. Y., Yoo, E. J., Choi, M. & Shin, S. H. et al. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin. Cancer Res. 15, 812-820 (2009
18. Bae, J. M., Shin, S. H., Kwon, H. J., Park, S. Y., Kook, M. C. & Kim, Y. W. et al. ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications. Int. J. Cancer 131, 1323-1331 (2011
19. Ehrlich, M. DNA methylation in cancer: too much, but also too little. Oncogene 21, 5400-5413 (2002
20. Frigola, J., Sole, X., Paz, M. F., Moreno, V., Esteller, M. & Capella, G. et al. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer. Hum. Mol. Genet. 14, 319-326 (2005
21. Saito, K., Kawakami, K., Matsumoto, I., Oda, M., Watanabe, G. & Minamoto, T. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer. Clin. Cancer Res. 16, 2418-2426 (2010
22. Kitkumthorn, N., Tuangsintanakul, T., Rattanatanyong, P., Tiwawech, D. & Mutirangura, A. LINE-1 methylation in the peripheral blood mononuclear cells of cancer patients. Clin. Chim. Acta. 413, 869-874 (2012
23. Chen, M., Chen, Z. Q., Cui, P. G., Yao, X., Li, Y. M. & Li, A. S. et al. The methylation pattern of p16INK4a gene promoter in psoriatic epidermis and its clinical significance. Br. J. Dermatol. 158, 987-993 (2008
24. Chen, M., Cui, P. G., Yao, X., Cao, Y. H., Gong, J. Q. & Li, A. S. et al. [The methylation locus and frequency pattern on p16 INK4a gene promoter CpG in epidermis of patients with psoriasis]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24, 674-676 (2007
25. Ruchusatsawat, K., Wongpiyabovorn, J., Shuangshoti, S., Hirankarn, N. & Mutirangura, A. SHP-1 promoter 2 methylation in normal epithelial tissues and demethylation in psoriasis. J. Mol. Med. 84, 175-182 (2006
26. Ruchusatsawat, K., Wongpiyabovorn, J., Protjaroen, P., Chaipipat, M., Shuangshoti, S. & Thorner, P. S. et al. Parakeratosis in skin is associated with loss of inhibitor of differentiation 4 via promoter methylation. Hum. Pathol. 42, 1878-1887 (2011
27. Zhang, P., Su, Y., Chen, H., Zhao, M. & Lu, Q. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J. Dermatol. Sci. 60, 40-42 (2010
28. Zhang, P., Su, Y., Zhao, M., Huang, W. & Lu, Q. Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris. Eur. J. Dermatol. 21, 552-557 (2011
29. Roberson, E. D., Liu, Y., Ryan, C., Joyce, C. E., Duan, S. & Cao, L. et al. A subset of methylated CpG sites differentiate psoriatic from normal skin. J. Invest. Dermatol. 132, 583-592 (2012
30. Gervin, K., Vigeland, M. D., Mattingsdal, M., Hammero, M., Nygard, H. & Olsen, A. O. et al. DNA methylation and gene expression changes in monozygotic twins discordant for psoriasis: identification of epigenetically dysregulated genes. PLoS Genet. 8, e1002454 (2012
31. Jintaridth, P. & Mutirangura, A. Distinctive patterns of age-dependent hypomethylation in interspersed repetitive sequences. Physiol. Genomics 41, 194-200 (2010
32. Penzkofer, T., Dandekar, T. & Zemojtel, T. L1Base: from functional annotation to prediction of active LINE-1 elements. Nucleic Acids Res. 33, D498-D500 (2005
33. Nair, R. P., Duffin, K. C., Helms, C., Ding, J., Stuart, P. E. & Goldgar, D. et al. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat. Genet. 41, 199-204 (2009
34. Yao, Y., Richman, L., Morehouse, C., De los Reyes, M., Higgs, B. W. & Boutrin, A. et al. Type I interferon: potential therapeutic target for psoriasis?. PLoS One 3, e2737 (2008
35. Sunami, E., De Maat, M., Vu, A., Turner, R. R. & Hoon, D. S. LINE-1 hypomethylation during primary colon cancer progression. PLoS One 6, e18884 (2011
36. Cash, H. L., Tao, L., Yuan, J. M., Marsit, C. J., Houseman, E. A. & Xiang, Y. B. et al. LINE-1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese. Int. J. Cancer 130, 1151-1159 (2011